Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Nina Kjellson
AddedMar 31, 2024
UpdatedMay 31, 2026
Nina Kjellson

Nina Kjellson

Board Member, Rondo Therapeutics

Crunchbase

Nina Kjellson's Career

Rondo Therapeutics
Rondo Therapeutics

Hayward, CA, US

Board Member· Board
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals

San Diego, CA, US

Board Member· Board
Alvine Pharmaceuticals
Alvine Pharmaceuticals

San Carlos, CA, US

Board Member· Board
Pact Pharma
Pact Pharma

Hayward, CA, US

Board Member· Board
Vineti
Vineti

San Francisco, CA, US

Board Member· Board
Tizona Therapeutics
Tizona Therapeutics

South San Francisco, CA, US

Board Member· Board
Welltok
Welltok

Denver, CO, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Nina Kjellson's Career

Rondo Therapeutics
Rondo Therapeutics
Series A$67M122019Hayward, CA, US
Board Member· Board

Leadership at Rondo Therapeutics

Shelley Force AldredShelley Force AldredFounder

Similar to Rondo Therapeutics

Immune-Onc TherapeuticsImmune-Onc TherapeuticsPalo Alto, CA, USCancer Treatmentest. 2016Immune-Onc TherapeuticsPalo Alto, CA, US · est. 2016

California-based Immune-Onc Therapeutics develops therapeutic antibodies for cancer treatment.

Public · $140.1M35
Soteria BiotherapeuticsSoteria BiotherapeuticsSan Francisco, CA, USCancer Therapiesest. 2018Soteria BiotherapeuticsSan Francisco, CA, US · est. 2018

Soteria: A biotech firm innovating safer, more effective cancer treatments via its T-LITE™ platform.

Series A · $42M11
Crossbow TherapeuticsCrossbow TherapeuticsCambridge, MA, USCancer Therapiesest. 2021Crossbow TherapeuticsCambridge, MA, US · est. 2021

Crossbow Therapeutics: A seed-stage startup innovating in antibody engineering for cancer targets.

Series B · $157M11
Trio PharmaceuticalsTrio PharmaceuticalsSan Diego, CA, USCancer Therapeuticsest. 2018Trio PharmaceuticalsSan Diego, CA, US · est. 2018

Innovative cancer therapeutics company developing affordable, dual-action treatments for enhanced efficacy and reduced toxicity.

Seed · $3.7M30
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals
Series A$40M112015San Diego, CA, US
Board Member· Board

Leadership at Dauntless Pharmaceuticals

Mike PowellMike PowellBoard Member
Joel MartinJoel MartinFounder
David S. KabakoffDavid S. KabakoffBoard Member

Similar to Dauntless Pharmaceuticals

Concours PharmaceuticalsConcours PharmaceuticalsTrenton, NJ, USPharmaceuticalsest. 2018Concours PharmaceuticalsTrenton, NJ, US · est. 2018

Concours Pharmaceuticals: Innovating oral drug delivery for advanced pharmaceutical development.

Seed · $2.7M30
Dose TherapeuticsDose TherapeuticsDallas, TX, USMedicinesest. 2021Dose TherapeuticsDallas, TX, US · est. 2021

Dose Therapeutics: A biotech firm innovating advanced medicines for unmet medical needs.

Series A · $10M5
Alvine Pharmaceuticals
Alvine Pharmaceuticals
Series A$68M112005San Carlos, CA, US
Board Member· Board

Leadership at Alvine Pharmaceuticals

Rod FergusonRod FergusonBoard Member
Patrick GagePatrick GageBoard Member
Don HaydenDon HaydenBoard Member

Similar to Alvine Pharmaceuticals

Aliva BiopharmaceuticalsAliva BiopharmaceuticalsPasadena, CA, USBiotechnologyest. 2009Aliva BiopharmaceuticalsPasadena, CA, US · est. 2009

Aliva Biopharmaceuticals: A leading innovator in the biotechnology industry.

Series A · $12.9M5
Avalyn PharmaAvalyn PharmaSeattle, WA, USPharmaceuticalsest. 2011Avalyn PharmaSeattle, WA, US · est. 2011

Avalyn Pharma Inc.: Developing innovative therapies for Idiopathic Pulmonary Fibrosis.

Series C · $272.5M27
Alavita PharmaceuticalsAlavita PharmaceuticalsMountain View, CA, USPharmaceuticalsest. 2005Alavita PharmaceuticalsMountain View, CA, US · est. 2005

Alavita Pharmaceuticals Inc.: Innovating in drug industry to reduce organ transplant failure.

Pre-Seed · $600k5
Alphina TherapeuticsAlphina TherapeuticsWestport, CT, USBiotechest. 2020Alphina TherapeuticsWestport, CT, US · est. 2020

Alphina Therapeutics: A biotech firm specializing in precision cancer medicine.

Series B · $16.9M8
Pact Pharma
Pact Pharma

Hayward, CA, US

Board Member· Board
Vineti
Vineti
Series C$115.3M3752016San Francisco, CA, US
Board Member· Board

Recent news

a16z-backed Rooms.xyz lets you build interactive, 3D rooms and simple games in your browserTechCrunch · 2023

Leadership at Vineti

Eli CasdinEli CasdinBoard Member
Stephen TingStephen TingCo-Founder
Emily MeltonEmily MeltonBoard Member
Amy DurossAmy DurossCo-Founder
Heidi HagenHeidi HagenCo-Founder
Ann KleinAnn KleinCEO

Similar to Vineti

ViTToria BiotherapeuticsViTToria BiotherapeuticsPhiladelphia, PA, USCell Therapiesest. 2021ViTToria BiotherapeuticsPhiladelphia, PA, US · est. 2021

Vittoria Biotherapeutics pioneers in gene-edited T-cell therapies, enhancing efficacy and safety in cell-based treatments.

Series B · $25M34
VintaBioVintaBioPhiladelphia, PA, USViral Vectorsest. 2020VintaBioPhiladelphia, PA, US · est. 2020

VintaBio: Expert CDMO provider for viral vectors, advancing cell and gene therapy manufacturing.

Series D · $64M15
Endpoint HealthEndpoint HealthPalo Alto, CA, USTests, Therapeuticsest. 2018Endpoint HealthPalo Alto, CA, US · est. 2018

Endpoint Health: Personalized therapies for immune-driven illnesses, improving patient outcomes.

Series D · $64.2M
Tizona Therapeutics
Tizona Therapeutics
Late Stage Private$370M462015South San Francisco, CA, US
Board Member· Board

Leadership at Tizona Therapeutics

Charles DrakeCharles DrakeCo-Founder
Dario VignaliDario VignaliCo-Founder
Drew PardollDrew PardollCo-Founder
Vijay KuchrooVijay KuchrooCo-Founder
Kurt von EmsterKurt von EmsterBoard Member
Christine O’BrienChristine O’BrienCEO

Similar to Tizona Therapeutics

Tigris PharmaceuticalsTigris PharmaceuticalsBonita Springs, FL, USCancer Treatmentsest. 2005Tigris PharmaceuticalsBonita Springs, FL, US · est. 2005

Tigris Pharmaceuticals: Innovating biopharmaceutical solutions for cancer and other medical needs.

Series C · $32.5M6
Immune-Onc TherapeuticsImmune-Onc TherapeuticsPalo Alto, CA, USCancer Treatmentest. 2016Immune-Onc TherapeuticsPalo Alto, CA, US · est. 2016

California-based Immune-Onc Therapeutics develops therapeutic antibodies for cancer treatment.

Public · $140.1M35
Welltok
Welltok
Series E$262.2M2002009Denver, CO, US
Board Member· Board

Leadership at Welltok

Mohamad MakhzoumiMohamad MakhzoumiBoard Member
Jeffrey MargolisJeffrey MargolisBoard Member
Bob FabbioBob FabbioCEO
Stephen KrausStephen KrausBoard Member
Kevin SpainKevin SpainBoard Member
Scott RotermundScott RotermundCo-Founder

Similar to Welltok

WellWellChapel Hill, NC, USHealth Technologyest. 2019WellChapel Hill, NC, US · est. 2019

Well: Advancing individualized health through effective health technology and services.

Series B · $136.8M275
WellableWellableBoston, MA, USWellness Programsest. 2013WellableBoston, MA, US · est. 2013

Wellable: A wellness tech platform offering customizable employee wellness programs to boost workplace culture.

Angel · $100k375
WellRightWellRightChicago, IL, USWellness Softwareest. 2013WellRightChicago, IL, US · est. 2013

WellRight: A wellness software provider offering personalized, flexible employee engagement programs.

Series B · $4.6M115

Nina Kjellson's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailHiroshi MikitaniHiroshi MikitaniBoard Member · RakutenKen KutaragiKen KutaragiBoard Member · RakutenTakashi MitachiTakashi MitachiBoard Member · Rakuten

People Similar to Nina Kjellson

Karan TakharKaran TakharBoard Member · Palleon PharmaceuticalsBrett ZbarBrett ZbarBoard Member · JavaraArjun GoyalArjun GoyalCo-Founder · Vida VenturesBrent AhrensBrent AhrensBoard Member · AbyrxIvor RoystonIvor RoystonBoard Member · BioceptNiall O'DonnellNiall O'DonnellBoard Member · Spruce Biosciences